A New Policy Regarding Ovarian Resection in Young Women Treated for Peritoneal Carcinomatosis

Elias, Dominique; Duchalais, Emilie; Dartigues, Peggy; Duvillard, Pierre; Poirot, Catherine; Goéré, Diane
June 2013
Annals of Surgical Oncology: An Oncology Journal for Surgeons;Jun2013, Vol. 20 Issue 6, p1837
Academic Journal
No abstract available.


Related Articles

  • Peritonectomy for Peritoneal Carcinomatosis: Long-Term Outcomes from a Single Brazilian Institution. Akaishi, Eduardo; Teixeira, Frederico; Katayama, Marcelo; Mizumoto, Nelson; Costa, Frederico P.; Buzaid, Antonio Carlos; Hoff, Paulo M. // World Journal of Surgery;Apr2009, Vol. 33 Issue 4, p835 

    The objective of this study was to evaluate the long-term outcomes of a single institution, Hospital Sírio-Libanes in São Paulo, Brazil, regarding the treatment of peritoneal carcinomatosis. Between October 2002 and October 2006, 46 consecutive patients were treated with radical...

  • Administration of CDDP Via the Superior Mesenteric Artery for Peritoneal Carcinomatosis due to Gastric Cancer. Taniguchi, Hiroki; Daidoh, Takeshi; Itoh, Akiyoshi; Horie, Horoshi; Yamaguchi, Toshiharu; Kojima, Osamu // American Journal of Gastroenterology;Jul1990, Vol. 85 Issue 7, p899 

    Presents a letter to the editor about the administration of CDDP or cisplatin for treating peritoneal carcinomatosis.

  • Blast Abdominal Tumors. Harrar, Safí; Rasich, Paula // Prevention;Jul2003, Vol. 55 Issue 7, p161 

    Presents the results of a study on the effectiveness of combining surgery and chemotherapy in treating peritoneal carcinomatosis. Background on peritoneal carcinomatosis, a kind of abdominal tumor; Benefits of the combination in prolonging the survival time of peritoneal carcinomatosis patients.

  • AN INTRAABDOMINAL ABSCESS AND PLEURAL EFFUSION AFTER CYTOREDUCTIVE SURGERY AND HIPEC. Kaya, Bülent; Esen, Nuriye; Bat, Orhan; Şener, Aziz; Cezik, Azime // Journal of Surgical Arts / Cerrahi Sanatlar Dergisi;2015, Vol. 8 Issue 2, p64 

    Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) has became a new treatment option in last years form any patients with peritoneal metastasis. In this case report, a 42 years old women was operated by gynecologists due to pelvic mass. On exploration, there was huge...

  • TB Peritonitis Mistaken for Ovarian Carcinomatosis Based on an Elevated CA-125. Boss, Joseph D.; Shah, Christopher T.; Oluwole, Oladoyin; Sheagren, John N. // Case Reports in Medicine;2012, p1 

    Background. In the United States, tuberculosis (TB) is of relatively low prevalence and most newly diagnosed patients are born outside of the United States. In addition, a large percentage (20.6%) of TB cases initially present with extrapulmonary manifestations (CDC, 2010). Cases of TB...

  • Peritoneal surface oncology: review of a personal experience with colorectal and appendiceal malignancy. Sugarbaker, P. H. // Techniques in Coloproctology;Jul2005, Vol. 9 Issue 2, p95 

    Peritoneal surface malignancy usually results from implantation of gastrointestinal cancer. In the past, this clinical situation was treated with palliative intent. A definitive approach to peritoneal surface malignancy involves peritonectomy procedures, visceral resections, perioperative...

  • Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer. Harmon, Rhonda L.; Sugarbaker, Paul H. // International Seminars in Surgical Oncology;2005, Vol. 2, p3 

    Peritoneal carcinomatosis from gastrointestinal cancer has new treatment options for surgical management. The approach uses cytoreductive surgery which combines peritonectomy and visceral resection in an effort to remove all visible cancer within the abdomen and pelvis. Then the peritoneal...

  • Perspective randomized trial evaluating mandatory second look surgery with HIPEC and CRS vs. standard of care in patients at high risk of developing colorectal peritoneal metastases. Ripley, Robert T.; Davis, Jeremy L.; Kemp, Clinton D.; Steinberg, Seth M.; Toomey, Mary Ann; Avital, Itzhak // Trials;2010, Vol. 11, p62 

    Background: The standard of care for colorectal peritoneal carcinomatosis is evolving from chemotherapy to cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with disease limited to the peritoneum. Peritoneal carcinomatosis from colorectal cancer...

  • Cytoreductive surgery (SRC) and hyperthermic intraperitoneal chemotherapy (HIPEC) for treatment of peritoneal carcinomatosis: Our initial experience and technical details. Topgül, Koray; Çetinkaya, Mehmet Bilge; Arslan, N. Çiğdem; Gül, Mustafa Kemal; Çan, Murat; Gürsel, Mahmut Fikret; Erdem, Dilek; Malazgirt, Zafer // Turkish Journal of Surgery / Ulusal Cerrahi Dergisi;2015, Vol. 31 Issue 3, p138 

    Objective: The aim of this study is to present our initial experience in peritoneal carcinomatosis treatment and the technical details of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in the light of current literature. Material and Methods: Data of 27...

  • Comparison of hyperthermia and adrenaline to enhance the intratumoral accumulation of cisplatin in a murin model of peritoneal carcinomatosis. Facy, Olivier; Radais, François; Ladoire, Sylvain; Delroeux, Delphine; Tixier, Hervé; Ghiringhelli, François; Rat, Patrick; Chauffert, Bruno; Ortega-Deballon, Pablo // Journal of Experimental & Clinical Cancer Research (17569966);2011, Vol. 30 Issue 1, p1 

    Background: The best method to deliver intraperitoneal chemotherapy (IPC) for peritoneal carcinomatosis from ovarian cancer is not well defined. The aim of this study was to assess the ability of hyperthermia and adrenaline to enhance the intratumoral accumulation of cisplatin in a rat model of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics